CDK7 inhibition is a novel therapeutic strategy against GBM both in vitro and in vivo

BACKGROUND: Glioblastoma multiforme (GBM) remains to be one of the top lethal cancer types for adult to date. Current GBM therapies suffer greatly from the highly heterogeneous and adaptable nature of GBM cells, indicating an urgent need of alternative therapeutic options. In this study, we focused...

Descripción completa

Detalles Bibliográficos
Autores principales: Meng, Wei, Wang, Jiajia, Wang, Baocheng, Liu, Fang, Li, Meng, Zhao, Yang, Zhang, Chenran, Li, Qifeng, Chen, Juxiang, Zhang, Liye, Tang, Yujie, Ma, Jie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6245350/
https://www.ncbi.nlm.nih.gov/pubmed/30532595
http://dx.doi.org/10.2147/CMAR.S183696

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6245350/
https://www.ncbi.nlm.nih.gov/pubmed/30532595
http://dx.doi.org/10.2147/CMAR.S183696

Ejemplares similares